Form 4: Cibus Inc. Executive Sells 2,000 Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Gregory Francis William Gocal, Chief Scientific Officer & EVP of Cibus, Inc., sold 2,000 shares of Class A Common Stock on July 12, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Gregory Francis William Gocal, the Chief Scientific Officer & EVP of Cibus, Inc. (CBUS), sold 2,000 shares of Class A Common Stock on July 12, 2024.
- The sale was executed at a price of $10 per share.
- The transaction was conducted under a Rule 10b5-1 trading plan adopted on March 27, 2024.
- Following the transaction, Gocal directly owns 316,844 shares of Cibus, Inc.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding an insider stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
This is a routine disclosure of an insider stock sale. It is common for executives to use 10b5-1 trading plans to avoid accusations of trading on inside information.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the pre-planned nature of the transaction.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date the reporting person adopted a Rule 10b5-1 trading plan |
| 07/12/2024 | Date of the transaction (sale of shares) |
| 07/15/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.